Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.

Aerobic exercise eases dysmenorrhoea-related pain

12 Jul 2019
Are women just over-exaggerating about dysmenorrhoea being labelled "almost as bad as having heart-attack", or is there some truth to it?

Aerobic exercise appears to ease dysmenorrhoea-related pain and improve quality of life (QoL) and daily functioning, a recent study has found.

Researchers randomly assigned 70 women with primary dysmenorrhoea to receive either a 4-week supervised aerobic training regimen or usual care. The primary outcome was pain, while secondary outcomes were quality of life, sleep and daily functioning.

Compared with the control scenario, the exercise regimen yielded significant improvements in pain intensity (visual analogue scale: mean difference, –4.7, 95 percent CI, –9.3 to –0.09) and pain quality (pain rating index: mean difference, –1.9, –3.8 to –0.04). These effects persisted until 4 and 7 months.

Moreover, improvements in present pain achieved statistical significance by 4 months (mean difference, –0.44, –0.72 to –0.16), which persisted until 7 months.

In terms of secondary outcomes, only the change in pain interference achieved statistical significance after 1 month (mean difference, –1.7, –3.4 to –0.02) and likewise persisted until 4 and 7 months.

In comparison, improvements in the physical (mean difference, 4.0, 1.6–6.4) and mental (mean difference, 2.8, 1.0–4.7) component summaries became significant starting month 4. The same was true for pain severity (mean difference, –2.3, –3.9 to –0.78) and percent pain relief (mean difference, 5.1, 2.0–8.3).

On the other hand, the exercise intervention elicited no significant improvements in sleep relative to usual care across all time points.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.